WO2014083546A3 - Method of determining effect of anti-obesity molecule - Google Patents

Method of determining effect of anti-obesity molecule Download PDF

Info

Publication number
WO2014083546A3
WO2014083546A3 PCT/IB2013/060517 IB2013060517W WO2014083546A3 WO 2014083546 A3 WO2014083546 A3 WO 2014083546A3 IB 2013060517 W IB2013060517 W IB 2013060517W WO 2014083546 A3 WO2014083546 A3 WO 2014083546A3
Authority
WO
WIPO (PCT)
Prior art keywords
molecule
reduce
determining effect
obesity
determining
Prior art date
Application number
PCT/IB2013/060517
Other languages
French (fr)
Other versions
WO2014083546A2 (en
Inventor
Gaiti Hasan
Manivannan SUBRAMANIAN
Original Assignee
National Centre For Biological Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Centre For Biological Sciences filed Critical National Centre For Biological Sciences
Publication of WO2014083546A2 publication Critical patent/WO2014083546A2/en
Publication of WO2014083546A3 publication Critical patent/WO2014083546A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure

Abstract

The present disclosure relates to a method of determining the anti-obesity effect of a molecule, using mutant Drosophila strains. Specifically, the instant disclosure is useful for testing drugs developed to reduce appetite, reduce fatty acid uptake from the intestine and reduce excess fat deposits.
PCT/IB2013/060517 2012-11-30 2013-11-29 Method of determining effect of anti-obesity molecule WO2014083546A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2180/CHE/2012 2012-11-30
IN2180CH2012 2012-11-30

Publications (2)

Publication Number Publication Date
WO2014083546A2 WO2014083546A2 (en) 2014-06-05
WO2014083546A3 true WO2014083546A3 (en) 2014-08-07

Family

ID=50828564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/060517 WO2014083546A2 (en) 2012-11-30 2013-11-29 Method of determining effect of anti-obesity molecule

Country Status (1)

Country Link
WO (1) WO2014083546A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188771A (en) * 2013-03-15 2015-12-23 诺姆奥克塞斯公司 Myo-inositol trispyrophosphate as an anti-obesity agent
CN113899709B (en) * 2021-09-10 2022-07-19 中国水产科学研究院珠江水产研究所 Method for quantitatively detecting deposition amount of fish mesentery fat and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080075664A1 (en) * 2006-09-01 2008-03-27 University Of Southern California Control Of Diabetes And Obesity
US20110130452A1 (en) * 2009-11-30 2011-06-02 Intellectual Ventures Asia Private Limited Store-operated calcium cellular assay

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080075664A1 (en) * 2006-09-01 2008-03-27 University Of Southern California Control Of Diabetes And Obesity
US20110130452A1 (en) * 2009-11-30 2011-06-02 Intellectual Ventures Asia Private Limited Store-operated calcium cellular assay

Also Published As

Publication number Publication date
WO2014083546A2 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
EP2686682A4 (en) Method of correlated mutational analysis to improve therapeutic antibodies
PT3412676T (en) Method for the preparation of cyclic boronic acid ester derivatives
WO2012159051A3 (en) Chemically modified graphene
EP2796555A4 (en) Method for producing l-lysine using microorganisms having ability to produce l-lysine
BR112012024799A2 (en) Method for the production of l-ornithine by fermentation
EA201690520A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
HUE037511T2 (en) Process for the preparation of tuluenediamine by hydrogenation of dinitrotoluene
BR112012029985A2 (en) methods for determining beta-amyloid blood turnover.
IL229647A0 (en) Novel process for the preparation of prostaglandin amides
HUP1100701A2 (en) Novel process for the preparation of travoprost
GEP20146183B (en) Process for preparation of l-arginine salt of perindopril
IN2013CH04906A (en)
WO2014083546A3 (en) Method of determining effect of anti-obesity molecule
WO2014068333A3 (en) New process
IN2014DN03245A (en)
WO2013040062A3 (en) Characterizing multiple sclerosis
UA110626C2 (en) Process for preparing pan-cdk inhibitors of the formula (i), and also to intermediates in the preparation
WO2013096976A3 (en) Process conditions for producing acrylic acid
WO2014184756A3 (en) Process for preparation of arformoterol of salt thereof
WO2012159981A3 (en) PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS
PL2534948T3 (en) Method of preparation of aqueuous dispersions of 1,2-Benzisothiazoline-3-one
EP2755990B8 (en) Method for preparation of betulinic acid
WO2013046233A3 (en) Process for the preparation of octreotide acetate
EP2755989A4 (en) Method for preparation of betulinic acid

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13858175

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase

Ref document number: 13858175

Country of ref document: EP

Kind code of ref document: A2